Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Pathway analysis of genetic variants in folate-mediated one-carbon metabolism-related genes and survival in a prospectively followed cohort of colorectal cancer patients.

Ose J, Botma A, Balavarca Y, Buck K, Scherer D, Habermann N, Beyerle J, Pfütze K, Seibold P, Kap EJ, Benner A, Jansen L, Butterbach K, Hoffmeister M, Brenner H, Ulrich A, Schneider M, Chang-Claude J, Burwinkel B, Ulrich CM.

Cancer Med. 2018 May 29. doi: 10.1002/cam4.1407. [Epub ahead of print]

2.

Associations of branched-chain amino acids with parameters of energy balance and survival in colorectal cancer patients: Results from the ColoCare Study.

Delphan M, Lin T, Liesenfeld DB, Nattenmüller J, Böhm JT, Gigic B, Habermann N, Zielske L, Schrotz-King P, Schneider M, Ulrich A, Kauczor HU, Ulrich CM, Ose J.

Metabolomics. 2018 Mar;2018(14). pii: 22. doi: 10.1007/s11306-017-1314-8. Epub 2018 Jan 31.

3.

Robust prediction of gene regulation in colorectal cancer tissues from DNA methylation profiles.

Klett H, Balavarca Y, Toth R, Gigic B, Habermann N, Scherer D, Schrotz-King P, Ulrich A, Schirmacher P, Herpel E, Brenner H, Ulrich CM, Michels KB, Busch H, Boerries M.

Epigenetics. 2018 May 3:1-12. doi: 10.1080/15592294.2018.1460034. [Epub ahead of print]

PMID:
29697014
4.

L-Thyroxine intake as a potential risk factor for the development of fatigue in breast cancer patients undergoing chemotherapy.

Schmidt ME, Wiskemann J, Johnson T, Habermann N, Schneeweiss A, Steindorf K.

Support Care Cancer. 2018 Feb 14. doi: 10.1007/s00520-018-4095-3. [Epub ahead of print]

PMID:
29445858
5.

Associations Between Dietary Patterns and Longitudinal Quality of Life Changes in Colorectal Cancer Patients: The ColoCare Study.

Gigic B, Boeing H, Toth R, Böhm J, Habermann N, Scherer D, Schrotz-King P, Abbenhardt-Martin C, Skender S, Brenner H, Chang-Claude J, Hoffmeister M, Syrjala K, Jacobsen PB, Schneider M, Ulrich A, Ulrich CM.

Nutr Cancer. 2018 Jan;70(1):51-60. doi: 10.1080/01635581.2018.1397707. Epub 2017 Dec 15.

6.

Effects of physical exercise on markers of inflammation in breast cancer patients during adjuvant chemotherapy.

van Vulpen JK, Schmidt ME, Velthuis MJ, Wiskemann J, Schneeweiss A, Vermeulen RCH, Habermann N, Ulrich CM, Peeters PHM, van der Wall E, May AM, Steindorf K.

Breast Cancer Res Treat. 2018 Apr;168(2):421-431. doi: 10.1007/s10549-017-4608-7. Epub 2017 Dec 12.

PMID:
29235043
7.

Smoking is associated with hypermethylation of the APC 1A promoter in colorectal cancer: the ColoCare Study.

Barrow TM, Klett H, Toth R, Böhm J, Gigic B, Habermann N, Scherer D, Schrotz-King P, Skender S, Abbenhardt-Martin C, Zielske L, Schneider M, Ulrich A, Schirmacher P, Herpel E, Brenner H, Busch H, Boerries M, Ulrich CM, Michels KB.

J Pathol. 2017 Nov;243(3):366-375. doi: 10.1002/path.4955. Epub 2017 Sep 29.

PMID:
28791728
8.

The effects of intermittent calorie restriction on metabolic health: Rationale and study design of the HELENA Trial.

Schübel R, Graf ME, Nattenmüller J, Nabers D, Sookthai D, Gruner LF, Johnson T, Schlett CL, von Stackelberg O, Kirsten R, Habermann N, Kratz M, Kauczor HU, Ulrich CM, Kaaks R, Kühn T.

Contemp Clin Trials. 2016 Nov;51:28-33. doi: 10.1016/j.cct.2016.09.004. Epub 2016 Sep 28.

PMID:
27687742
9.

Discovery of novel plasma proteins as biomarkers for the development of incisional hernias after midline incision in patients with colorectal cancer: The ColoCare study.

Böhm J, Pianka F, Stüttgen N, Rho J, Gigic B, Zhang Y, Habermann N, Schrotz-King P, Abbenhardt-Martin C, Zielske L, Lampe PD, Ulrich A, Diener MK, Ulrich CM.

Surgery. 2017 Mar;161(3):808-817. doi: 10.1016/j.surg.2016.08.025. Epub 2016 Oct 13.

10.

Using large-scale genome variation cohorts to decipher the molecular mechanism of cancer.

Habermann N, Mardin BR, Yakneen S, Korbel JO.

C R Biol. 2016 Jul-Aug;339(7-8):308-13. doi: 10.1016/j.crvi.2016.05.008. Epub 2016 Jun 21. Review.

PMID:
27342254
11.

TLR8 regulation of LILRA3 in monocytes is abrogated in human immunodeficiency virus infection and correlates to CD4 counts and virus loads.

Low HZ, Ahrenstorf G, Pommerenke C, Habermann N, Schughart K, Ordóñez D, Stripecke R, Wilk E, Witte T.

Retrovirology. 2016 Mar 12;13:15. doi: 10.1186/s12977-016-0248-y.

12.

Resistance Exercise and Inflammation in Breast Cancer Patients Undergoing Adjuvant Radiation Therapy: Mediation Analysis From a Randomized, Controlled Intervention Trial.

Schmidt ME, Meynköhn A, Habermann N, Wiskemann J, Oelmann J, Hof H, Wessels S, Klassen O, Debus J, Potthoff K, Steindorf K, Ulrich CM.

Int J Radiat Oncol Biol Phys. 2016 Feb 1;94(2):329-37. doi: 10.1016/j.ijrobp.2015.10.058. Epub 2015 Nov 2.

PMID:
26853341
13.

SNPs in transporter and metabolizing genes as predictive markers for oxaliplatin treatment in colorectal cancer patients.

Kap EJ, Seibold P, Scherer D, Habermann N, Balavarca Y, Jansen L, Zucknick M, Becker N, Hoffmeister M, Ulrich A, Benner A, Ulrich CM, Burwinkel B, Brenner H, Chang-Claude J.

Int J Cancer. 2016 Jun 15;138(12):2993-3001. doi: 10.1002/ijc.30026. Epub 2016 Feb 19.

14.

Aspirin Reduces Plasma Concentrations of the Oncometabolite 2-Hydroxyglutarate: Results of a Randomized, Double-Blind, Crossover Trial.

Liesenfeld DB, Botma A, Habermann N, Toth R, Weigel C, Popanda O, Klika KD, Potter JD, Lampe JW, Ulrich CM.

Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):180-7. doi: 10.1158/1055-9965.EPI-15-0697. Epub 2015 Nov 19.

15.

Cancer-related fatigue shows a stable association with diurnal cortisol dysregulation in breast cancer patients.

Schmidt ME, Semik J, Habermann N, Wiskemann J, Ulrich CM, Steindorf K.

Brain Behav Immun. 2016 Feb;52:98-105. doi: 10.1016/j.bbi.2015.10.005. Epub 2015 Oct 9.

PMID:
26456694
16.

Changes in urinary metabolic profiles of colorectal cancer patients enrolled in a prospective cohort study (ColoCare).

Liesenfeld DB, Habermann N, Toth R, Owen RW, Frei E, Staffa J, Schrotz-King P, Klika KD, Ulrich CM.

Metabolomics (Los Angel). 2015 Aug;11(4):998-1012. doi: 10.1007/s11306-014-0758-3. Epub 2014 Dec 20.

17.

Metabolomics and transcriptomics identify pathway differences between visceral and subcutaneous adipose tissue in colorectal cancer patients: the ColoCare study.

Liesenfeld DB, Grapov D, Fahrmann JF, Salou M, Scherer D, Toth R, Habermann N, Böhm J, Schrotz-King P, Gigic B, Schneider M, Ulrich A, Herpel E, Schirmacher P, Fiehn O, Lampe JW, Ulrich CM.

Am J Clin Nutr. 2015 Aug;102(2):433-43. doi: 10.3945/ajcn.114.103804. Epub 2015 Jul 8.

18.

Folate-mediated one-carbon metabolism genes and interactions with nutritional factors on colorectal cancer risk: Women's Health Initiative Observational Study.

Cheng TY, Makar KW, Neuhouser ML, Miller JW, Song X, Brown EC, Beresford SA, Zheng Y, Poole EM, Galbraith RL, Duggan DJ, Habermann N, Bailey LB, Maneval DR, Caudill MA, Toriola AT, Green R, Ulrich CM.

Cancer. 2015 Oct 15;121(20):3684-91. doi: 10.1002/cncr.29465. Epub 2015 Jun 24.

19.

Genetic variants in DNA repair genes as potential predictive markers for oxaliplatin chemotherapy in colorectal cancer.

Kap EJ, Seibold P, Richter S, Scherer D, Habermann N, Balavarca Y, Jansen L, Becker N, Pfütze K, Popanda O, Hoffmeister M, Ulrich A, Benner A, Ulrich CM, Burwinkel B, Brenner H, Chang-Claude J.

Pharmacogenomics J. 2015 Dec;15(6):505-12. doi: 10.1038/tpj.2015.8. Epub 2015 Mar 17.

20.

Biotransformation of xenobiotics in the human colon and rectum and its association with colorectal cancer.

Beyerle J, Frei E, Stiborova M, Habermann N, Ulrich CM.

Drug Metab Rev. 2015 May;47(2):199-221. doi: 10.3109/03602532.2014.996649. Epub 2015 Feb 17. Review.

PMID:
25686853
21.

Suitability of circulating miRNAs as potential prognostic markers in colorectal cancer.

Ristau J, Staffa J, Schrotz-King P, Gigic B, Makar KW, Hoffmeister M, Brenner H, Ulrich A, Schneider M, Ulrich CM, Habermann N.

Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2632-7. doi: 10.1158/1055-9965.EPI-14-0556.

22.

Potential of fecal microbiota for early-stage detection of colorectal cancer.

Zeller G, Tap J, Voigt AY, Sunagawa S, Kultima JR, Costea PI, Amiot A, Böhm J, Brunetti F, Habermann N, Hercog R, Koch M, Luciani A, Mende DR, Schneider MA, Schrotz-King P, Tournigand C, Tran Van Nhieu J, Yamada T, Zimmermann J, Benes V, Kloor M, Ulrich CM, von Knebel Doeberitz M, Sobhani I, Bork P.

Mol Syst Biol. 2014 Nov 28;10:766. doi: 10.15252/msb.20145645.

23.

No effect of caloric restriction or exercise on radiation repair capacity.

Habermann N, Makar KW, Abbenhardt C, Xiao L, Wang CY, Utsugi HK, Alfano CM, Campbell KL, Duggan C, Foster-Schubert KE, Mason CE, Imayama I, Blackburn GL, Potter JD, McTiernan A, Ulrich CM.

Med Sci Sports Exerc. 2015 May;47(5):896-904. doi: 10.1249/MSS.0000000000000480.

24.

Randomized, controlled trial of resistance training in breast cancer patients receiving adjuvant radiotherapy: results on cancer-related fatigue and quality of life.

Steindorf K, Schmidt ME, Klassen O, Ulrich CM, Oelmann J, Habermann N, Beckhove P, Owen R, Debus J, Wiskemann J, Potthoff K.

Ann Oncol. 2014 Nov;25(11):2237-43. doi: 10.1093/annonc/mdu374. Epub 2014 Aug 5.

PMID:
25096607
25.

Genetic variation in prostaglandin synthesis and related pathways, NSAID use and colorectal cancer risk in the Colon Cancer Family Registry.

Resler AJ, Makar KW, Heath L, Whitton J, Potter JD, Poole EM, Habermann N, Scherer D, Duggan D, Wang H, Lindor NM, Passarelli MN, Baron JA, Newcomb PA, Le Marchand L, Ulrich CM.

Carcinogenesis. 2014 Sep;35(9):2121-6. doi: 10.1093/carcin/bgu119. Epub 2014 Jun 7.

26.

Review of mass spectrometry-based metabolomics in cancer research.

Liesenfeld DB, Habermann N, Owen RW, Scalbert A, Ulrich CM.

Cancer Epidemiol Biomarkers Prev. 2013 Dec;22(12):2182-201. doi: 10.1158/1055-9965.EPI-13-0584. Epub 2013 Oct 4. Review.

27.

Tumor-infiltrating lymphocytes in colorectal tumors display a diversity of T cell receptor sequences that differ from the T cells in adjacent mucosal tissue.

Sherwood AM, Emerson RO, Scherer D, Habermann N, Buck K, Staffa J, Desmarais C, Halama N, Jaeger D, Schirmacher P, Herpel E, Kloor M, Ulrich A, Schneider M, Ulrich CM, Robins H.

Cancer Immunol Immunother. 2013 Sep;62(9):1453-61. doi: 10.1007/s00262-013-1446-2. Epub 2013 Jun 16.

28.

Randomized controlled trial to evaluate the effects of progressive resistance training compared to progressive muscle relaxation in breast cancer patients undergoing adjuvant radiotherapy: the BEST study.

Potthoff K, Schmidt ME, Wiskemann J, Hof H, Klassen O, Habermann N, Beckhove P, Debus J, Ulrich CM, Steindorf K.

BMC Cancer. 2013 Mar 28;13:162. doi: 10.1186/1471-2407-13-162.

29.

Gene expression changes in adipose tissue with diet- and/or exercise-induced weight loss.

Campbell KL, Foster-Schubert KE, Makar KW, Kratz M, Hagman D, Schur EA, Habermann N, Horton M, Abbenhardt C, Kuan LY, Xiao L, Davison J, Morgan M, Wang CY, Duggan C, McTiernan A, Ulrich CM.

Cancer Prev Res (Phila). 2013 Mar;6(3):217-31. doi: 10.1158/1940-6207.CAPR-12-0212. Epub 2013 Jan 22.

30.

Progressive resistance versus relaxation training for breast cancer patients during adjuvant chemotherapy: design and rationale of a randomized controlled trial (BEATE study).

Schmidt ME, Wiskemann J, Krakowski-Roosen H, Knicker AJ, Habermann N, Schneeweiss A, Ulrich CM, Steindorf K.

Contemp Clin Trials. 2013 Jan;34(1):117-25. doi: 10.1016/j.cct.2012.10.006. Epub 2012 Oct 25.

PMID:
23103936
31.

PTGS1, PTGS2, ALOX5, ALOX12, ALOX15, and FLAP SNPs: interaction with fatty acids in colon cancer and rectal cancer.

Habermann N, Ulrich CM, Lundgreen A, Makar KW, Poole EM, Caan B, Kulmacz R, Whitton J, Galbraith R, Potter JD, Slattery ML.

Genes Nutr. 2013 Jan;8(1):115-26. doi: 10.1007/s12263-012-0302-x. Epub 2012 Jun 8.

32.

The utility of risk assessment instruments for the prediction of recidivism in sexual homicide perpetrators.

Hill A, Rettenberger M, Habermann N, Berner W, Eher R, Briken P.

J Interpers Violence. 2012 Dec;27(18):3553-78. doi: 10.1177/0886260512447570. Epub 2012 May 29.

PMID:
22645029
33.

Human colon cell culture models of different transformation stages to assess conjugated linoleic acid and conjugated linolenic acid metabolism: Challenges and chances.

Degen C, Habermann N, Piegholdt S, Glei M, Jahreis G.

Toxicol In Vitro. 2012 Sep;26(6):985-92. doi: 10.1016/j.tiv.2012.05.002. Epub 2012 May 11.

PMID:
22584027
34.

Sexual murderers with adult or child victims: are they different?

Spehr A, Hill A, Habermann N, Briken P, Berner W.

Sex Abuse. 2010 Sep;22(3):290-314. doi: 10.1177/1079063210374346. Erratum in: Sex Abuse. 2010 Dec;22(4):491.

PMID:
20713748
35.

Fish fatty acids alter markers of apoptosis in colorectal adenoma and adenocarcinoma cell lines but fish consumption has no impact on apoptosis-induction ex vivo.

Habermann N, Schön A, Lund EK, Glei M.

Apoptosis. 2010 May;15(5):621-30. doi: 10.1007/s10495-010-0459-y.

PMID:
20107900
36.

Increasing fish consumption does not affect genotoxicity markers in the colon in an intervention study.

Pot GK, Habermann N, Majsak-Newman G, Harvey LJ, Geelen A, Przybylska-Philips K, Nagengast FM, Witteman BJ, van de Meeberg PC, Hart AR, Schaafsma G, Hooiveld G, Glei M, Lund EK, Pool-Zobel BL, Kampman E.

Carcinogenesis. 2010 Jun;31(6):1087-91. doi: 10.1093/carcin/bgp255. Epub 2009 Oct 27.

PMID:
19861650
37.

Effects of fatty acids on metabolism and cell growth of human colon cell lines of different transformation state.

Habermann N, Christian B, Luckas B, Pool-Zobel BL, Lund EK, Glei M.

Biofactors. 2009 Sep-Oct;35(5):460-7. doi: 10.1002/biof.60.

PMID:
19798733
38.

[Antiandrogenic pharmacotherapy of sexual offenders and home leave steps in the forensic psychiatric hospital Berlin].

Briken P, Welzel K, Habermann N, Hill A, Berner W.

Psychiatr Prax. 2009 Jul;36(5):232-7. doi: 10.1055/s-0028-1090221. Epub 2009 May 12. German.

PMID:
19437383
39.

Mechanisms of primary cancer prevention by butyrate and other products formed during gut flora-mediated fermentation of dietary fibre.

Scharlau D, Borowicki A, Habermann N, Hofmann T, Klenow S, Miene C, Munjal U, Stein K, Glei M.

Mutat Res. 2009 Jul-Aug;682(1):39-53. doi: 10.1016/j.mrrev.2009.04.001. Epub 2009 Apr 19. Review.

PMID:
19383551
40.

Modulation of gene expression in eicosapentaenoic acid and docosahexaenoic acid treated human colon adenoma cells.

Habermann N, Lund EK, Pool-Zobel BL, Glei M.

Genes Nutr. 2009 Mar;4(1):73-6. doi: 10.1007/s12263-009-0112-y. Epub 2009 Feb 21.

41.

[Criminal responsibility in sexual homicide perpetrators].

Hill A, Ujeyl M, Habermann N, Berner W, Briken P.

Fortschr Neurol Psychiatr. 2008 Jun;76(6):343-53. doi: 10.1055/s-2008-1038194. German.

PMID:
18512185
42.

Apple polyphenols modulate expression of selected genes related to toxicological defence and stress response in human colon adenoma cells.

Veeriah S, Miene C, Habermann N, Hofmann T, Klenow S, Sauer J, Böhmer F, Wölfl S, Pool-Zobel BL.

Int J Cancer. 2008 Jun 15;122(12):2647-55. doi: 10.1002/ijc.23440.

43.

[Comparison of sexual murderers in forensic psychiatric hospitals and in prison].

Ujeyl M, Habermann N, Briken P, Berner W, Hill A.

Nervenarzt. 2008 May;79(5):587-93. doi: 10.1007/s00115-007-2394-x. German.

PMID:
18210041
44.

Criminal recidivism in sexual homicide perpetrators.

Hill A, Habermann N, Klusmann D, Berner W, Briken P.

Int J Offender Ther Comp Criminol. 2008 Feb;52(1):5-20. Epub 2007 Oct 22.

PMID:
17954927
45.

Bread enriched with green coffee extract has chemoprotective and antigenotoxic activities in human cells.

Glei M, Kirmse A, Habermann N, Persin C, Pool-Zobel BL.

Nutr Cancer. 2006;56(2):182-92.

PMID:
17474864
46.

Sexual sadism and sadistic personality disorder in sexual homicide.

Hill A, Habermann N, Berner W, Briken P.

J Pers Disord. 2006 Dec;20(6):671-84.

PMID:
17192143
47.

Psychiatric disorders in single and multiple sexual murderers.

Hill A, Habermann N, Berner W, Briken P.

Psychopathology. 2007;40(1):22-8. Epub 2006 Oct 19.

PMID:
17057421
48.

[Selective serotonine reuptake inhibitors (SSRI) in the treatment of paraphilia].

Kraus C, Strohm K, Hill A, Habermann N, Berner W, Briken P.

Fortschr Neurol Psychiatr. 2007 Jun;75(6):351-6. Epub 2006 Oct 10. German.

PMID:
17031776
49.

The paraphilia-related disorders: an investigation of the relevance of the concept in sexual murderers.

Briken P, Habermann N, Kafka MP, Berner W, Hill A.

J Forensic Sci. 2006 May;51(3):683-8.

PMID:
16696722
50.

XYY chromosome abnormality in sexual homicide perpetrators.

Briken P, Habermann N, Berner W, Hill A.

Am J Med Genet B Neuropsychiatr Genet. 2006 Mar 5;141B(2):198-200.

PMID:
16389589

Supplemental Content

Loading ...
Support Center